INTELLIGENT BIO SOLUTIONS INC. Increase (Decrease) in Inventories
INTELLIGENT BIO SOLUTIONS INC. (INBS) reported Increase (Decrease) in Inventories of -$216.64 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-19.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-19
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in inventories for the quarter ending 2026-06-30 was -$178.89K.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in inventories for the quarter ending 2026-03-31 was $7.22K.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in inventories for the quarter ending 2025-12-31 was -$37.93K.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in inventories for the quarter ending 2025-09-30 was -$7.04K.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in inventories for fiscal 2026 was -$216.64K.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in inventories for fiscal 2025 was -$142.32K.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in inventories for fiscal 2024 was -$202.37K, a 158.59% decline from fiscal 2023.
- INTELLIGENT BIO SOLUTIONS INC. increase (decrease) in inventories for fiscal 2023 was $345.39K.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$178.89K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-19 | -$171.67K derived: sum of 2 quarters · filed 2026-08-19 | -$209.60K derived: sum of 3 quarters · filed 2026-08-19 | -$216.64K 10-K · filed 2026-08-19 |
| 2026-03-31 | $7.22K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | -$30.71K derived: sum of 2 quarters · filed 2026-05-13 | -$37.75K 10-Q · filed 2026-05-13 | -$86.02K derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-12-31 | -$37.93K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-12 | -$44.97K 10-Q · filed 2026-02-12 | -$93.24K derived: sum of 3 quarters · filed 2026-08-19 | -$111.03K derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-09-30 | -$7.04K 10-Q · filed 2025-11-12 | -$55.31K derived: sum of 2 quarters · filed 2026-08-19 | -$73.10K derived: sum of 3 quarters · filed 2026-08-19 | -$110.61K derived: sum of 4 quarters · filed 2026-08-19 |
| 2025-06-30 | -$48.27K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-19 | -$66.06K derived: sum of 2 quarters · filed 2026-08-19 | -$103.57K derived: sum of 3 quarters · filed 2026-08-19 | -$142.32K 10-K · filed 2026-08-19 |
| 2025-03-31 | -$17.79K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | -$55.30K derived: sum of 2 quarters · filed 2026-05-13 | -$94.05K 10-Q · filed 2026-05-13 | -$194.42K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | -$37.51K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-12 | -$76.26K 10-Q · filed 2026-02-12 | -$176.63K derived: sum of 3 quarters · filed 2026-02-12 | -$309.79K derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-09-30 | -$38.75K 10-Q · filed 2025-11-12 | -$139.12K derived: sum of 2 quarters · filed 2025-11-12 | -$272.28K derived: sum of 3 quarters · filed 2025-11-12 | -$294.15K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$100.37K derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-15 | -$233.53K derived: sum of 2 quarters · filed 2025-08-15 | -$255.41K derived: sum of 3 quarters · filed 2025-08-15 | -$202.37K 10-K · filed 2025-08-15 |
| 2024-03-31 | -$133.16K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-13 | -$155.04K derived: sum of 2 quarters · filed 2025-05-13 | -$102.00K 10-Q · filed 2025-05-13 | $168.52K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$21.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-02-13 | $31.16K 10-Q · filed 2025-02-13 | $301.68K derived: sum of 3 quarters · filed 2025-02-13 | $341.40K derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-09-30 | $53.03K 10-Q · filed 2024-11-07 | $323.56K derived: sum of 2 quarters · filed 2024-11-07 | $363.28K derived: sum of 3 quarters · filed 2024-11-07 | |
| 2023-06-30 | $270.52K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-18 | $310.25K derived: sum of 2 quarters · filed 2024-09-18 | $345.39K 10-K · filed 2024-09-18 | |
| 2023-03-31 | $39.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-08 | $74.87K 10-Q · filed 2024-05-08 | ||
| 2022-12-31 | $35.15K 10-Q · filed 2024-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |